New Antivirals for Hepatitis C Infection Among Infected Kidney Transplant Recipients: A Case Report

2015 ◽  
Vol 47 (9) ◽  
pp. 2672-2674 ◽  
Author(s):  
A. Suarez-Benjumea ◽  
C. Gonzalez-Corvillo ◽  
G. Bernal-Blanco ◽  
J.M. Pascasio-Acevedo ◽  
F. Gonzalez-Roncero ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatitis C ◽  
Kidney Transplant ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Hepatitis C Infection

scholarly journals Infectious Complications Following Kidney Transplantation—A Focus on Hepatitis C Infection, Cytomegalovirus Infection and Novel Developments in the Gut Microbiota

Medicina ◽  
2019 ◽  
Vol 55 (10) ◽  
pp. 672 ◽  
Author(s):  
Chan ◽  
Isbel ◽  
Hawley ◽  
Campbell ◽  
Campbell ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Hepatitis C ◽  
Kidney Transplant ◽  
Infectious Complications ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Hepatitis C Infection ◽  
Gastrointestinal Microbiota ◽  
Donation Process ◽  
Wide Range

The incidence of infectious complications, compared with the general population and the pre-transplant status of the recipient, increases substantially following kidney transplantation, causing significant morbidity and mortality. The potent immunosuppressive therapy given to prevent graft rejection in kidney transplant recipients results in an increased susceptibility to a wide range of opportunistic infections including bacterial, viral and fungal infections. Over the last five years, several advances have occurred that may have changed the burden of infectious complications in kidney transplant recipients. Due to the availability of direct-acting antivirals to manage donor-derived hepatitis C infection, this has opened the way for donors with hepatitis C infection to be considered in the donation process. In addition, there have been the development of medications targeting the growing burden of resistant cytomegalovirus, as well as the discovery of the potentially important role of the gastrointestinal microbiota in the pathogenesis of post-transplant infection. In this narrative review, we will discuss these three advances and their potential implications for clinical practice.

scholarly journals Treatment of Hepatitis C Virus Infection in Kidney Transplant Recipients: Case Report

2011 ◽  
Vol 43 (1) ◽  
pp. 259-262 ◽  
Author(s):  
F. Caeiro ◽  
V. Baptista ◽  
N. Rodrigues ◽  
D. Carvalho ◽  
I. Aires ◽  
...  
Keyword(s):  
Case Report ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Kidney Transplant ◽  
Transplant Recipients ◽  
Hepatitis C Virus Infection ◽  
Kidney Transplant Recipients

Treatment of Chronic Hepatitis C Infection Among Egyptian Kidney Transplant Recipients: A Pilot Study

2019 ◽  
Vol 17 (Suppl 1) ◽  
pp. 62-67 ◽  
Author(s):  
Hanzada Mohamed El Maghrabi ◽  
◽  
Ahmed Yahia Elmowafy ◽  
Ahmed Farouk Donia ◽  
Mabrouk Ibrahim Ismail ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Pilot Study ◽  
Kidney Transplant ◽  
Chronic Hepatitis C ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Hepatitis C Infection

scholarly journals Everolimus-induced interstitial pneumonitis in a kidney transplant recipients: A case report

2017 ◽  
Author(s):  
Gulsah Sasak ◽  
Ebru Zemheri ◽  
Abdullah Ozkok ◽  
Kubra Aydın Bahat ◽  
Sabahat Alısır Ecder ◽  
...  
Keyword(s):  
Case Report ◽  
Kidney Transplant ◽  
Interstitial Pneumonitis ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

HEPATITIS C IS A POOR PROGNOSTIC INDICATOR IN BLACK KIDNEY TRANSPLANT RECIPIENTS

1993 ◽  
Vol 55 (6) ◽  
pp. 1283-1286 ◽  
Author(s):  
CLAIRE FRITSCHE ◽  
JAMES C. BRANDES ◽  
STEPHEN R. DELANEY ◽  
SUSAN GALLAGHER-LEPAK ◽  
JAY E. MENITOVE ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Kidney Transplant ◽  
Prognostic Indicator ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Poor Prognostic Indicator
Sign in / Sign up

Export Citation Format

Share Document